Baker Bros. Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,792,657
| Closed | -$92.6M | – | 126 |
|
|
2022
Q3 | $92.6M | Hold |
1,792,657
| – | – | 0.61% | 16 |
|
|
2022
Q2 | $44.4M | Buy |
1,792,657
+875,795
| +96% | +$19.3M | 0.25% | 27 |
|
|
2022
Q1 | $23M | Sell |
916,862
-714,404
| -44% | -$20.1M | 0.13% | 49 |
|
|
2021
Q4 | $59.4M | Buy |
1,631,266
+1,330,071
| +442% | +$46.7M | 0.29% | 31 |
|
|
2021
Q3 | $5.15M | Buy |
+301,195
| New | +$4.69M | 0.02% | 94 |
|
|
2021
Q2 | – | Sell |
-656,710
| Closed | -$33.6M | – | 132 |
|
|
2021
Q1 | $33.6M | Hold |
656,710
| – | – | 0.15% | 54 |
|
|
2020
Q4 | $40.7M | Sell |
656,710
-243,111
| -27% | -$13.9M | 0.15% | 40 |
|
|
2020
Q3 | $49.3M | Sell |
899,821
-45,400
| -5% | -$2.44M | 0.2% | 34 |
|
|
2020
Q2 | $54.4M | Buy |
945,221
+86,206
| +10% | +$4.69M | 0.24% | 33 |
|
|
2020
Q1 | $34.5M | Buy |
859,015
+119,999
| +16% | +$5.1M | 0.21% | 33 |
|
|
2019
Q4 | $29.2M | Buy |
739,016
+531,987
| +257% | +$9.34M | 0.16% | 41 |
|
|
2019
Q3 | $1.4M | Hold |
207,029
| – | – | 0.01% | 93 |
|
|
2019
Q2 | $1.93M | Hold |
207,029
| – | – | 0.01% | 87 |
|
|
2019
Q1 | $2.88M | Hold |
207,029
| – | – | 0.02% | 74 |
|
|
2018
Q4 | $2.26M | Sell |
207,029
-207,000
| -50% | -$2.18M | 0.02% | 71 |
|
|
2018
Q3 | $5.23M | Hold |
414,029
| – | – | 0.03% | 70 |
|
|
2018
Q2 | $5.45M | Hold |
414,029
| – | – | 0.04% | 72 |
|
|
2018
Q1 | $5.63M | Buy |
414,029
+364,965
| +744% | +$3.77M | 0.05% | 74 |
|
|
2017
Q4 | $292K | Hold |
49,064
| – | – | ﹤0.01% | 119 |
|
|
2017
Q3 | $364K | Hold |
49,064
| – | – | ﹤0.01% | 117 |
|
|
2017
Q2 | $459K | Hold |
49,064
| – | – | ﹤0.01% | 113 |
|
|
2017
Q1 | $357K | Hold |
49,064
| – | – | ﹤0.01% | 115 |
|
|
2016
Q4 | $363K | Hold |
49,064
| – | – | ﹤0.01% | 126 |
|
|
2016
Q3 | $296K | Hold |
49,064
| – | – | ﹤0.01% | 132 |
|
|
2016
Q2 | $220K | Hold |
49,064
| – | – | ﹤0.01% | 132 |
|
|
2016
Q1 | $122K | Hold |
49,064
| – | – | ﹤0.01% | 131 |
|
|
2015
Q4 | $397K | Hold |
49,064
| – | – | ﹤0.01% | 129 |
|
|
2015
Q3 | $297K | Hold |
49,064
| – | – | ﹤0.01% | 129 |
|
|
2015
Q2 | $404K | Hold |
49,064
| – | – | ﹤0.01% | 123 |
|
|
2015
Q1 | $370K | Sell |
49,064
-936
| -2% | -$7.31K | ﹤0.01% | 126 |
|
|
2014
Q4 | $342K | Hold |
50,000
| – | – | ﹤0.01% | 118 |
|
|
2014
Q3 | $225K | Hold |
50,000
| – | – | ﹤0.01% | 107 |
|
|
2014
Q2 | $293K | Hold |
50,000
| – | – | ﹤0.01% | 104 |
|
|
2014
Q1 | $332K | Hold |
50,000
| – | – | ﹤0.01% | 107 |
|
|
2013
Q4 | $290K | Sell |
50,000
-150,000
| -75% | -$773K | ﹤0.01% | 94 |
|
|
2013
Q3 | $1.11M | Sell |
200,000
-175,000
| -47% | -$1.89M | 0.02% | 77 |
|
|
2013
Q2 | $5.3M | Buy |
+375,000
| New | +$4.86M | 0.1% | 45 |
|
Other funds holding CCXI
Baker Bros. Advisors's CCXI Position: Q4 2022 in Review
Baker Bros. Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,792,657 shares — an estimated $92.6M sold.
Baker Bros. Advisors first reported a position in CCXI in Q2 2013 and held it in 37 quarters. The position peaked at $92.6M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Baker Bros. Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Baker Bros. Advisors sold 1,792,657 ChemoCentryx, Inc. shares in Q4 2022, an estimated $92.6M.
- Baker Bros. Advisors first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 37 quarters.
- Baker Bros. Advisors's ChemoCentryx, Inc. position peaked at $92.6M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Baker Bros. Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.